Skip to main content
Veterinary Medicines

Poulvac IB Primer, liofilizatas purškiamajai, lašinamajai į akį ar geriamajai su vandeniu suspensijai ruošti vištoms

Authorised
  • Avian infectious bronchitis virus, strain D274, Live
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live

Product identification

Medicine name:
Poulvac IB Primer, liofilizatas purškiamajai, lašinamajai į akį ar geriamajai su vandeniu suspensijai ruošti vištoms
Active substance:
  • Avian infectious bronchitis virus, strain D274, Live
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
Target species:
  • Chicken
Route of administration:
  • Nebulisation use
  • Intraocular use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, strain D274, Live
    1000.00
    50% Embryo Infective Dose
    /
    1.00
    Dose
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
    1000.00
    50% Embryo Infective Dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oral suspension
Withdrawal period by route of administration:
  • Nebulisation use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
  • Intraocular use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD07
Authorisation status:
  • Valid
Authorised in:
  • Lithuania

Additional information

Entitlement type:
  • Parallel Trade Approval
Marketing authorisation date:
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • B1-865
Parallel trade in reference of:
Parallel trade of:
Source wholesaler:
  • Vetmarket SIA
Destination wholesaler:
  • Vetmarket UAB
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."